Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -12.42 | N/A |
PEG Ratio (TTM) | 0.01 | N/A |
P/S Ratio (TTM) | 1.01 | N/A |
P/B Ratio (TTM) | 1,977.33 | N/A |
P/FCF Ratio (TTM) | -105.86 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.75% | N/A |
ROE (TTM) | -59.89% | N/A |
Net Profit Margin (TTM) | -6.81% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -861.71% | 72.82% | N/A |
Revenue | 1.81% | 26,643.76% | N/A |
Net Income | -967.02% | 516,706.06% | N/A |
Cash Flow | 25.10% | 180.11% | N/A |
Health (30%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.33 | N/A |
Quick Ratio (TTM) | 1.33 | N/A |
D/E Ratio (TTM) | 222.15 | N/A |
Interest Coverage (TTM) | -0.30 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 2.26 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |